CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Nicola Ivan LoréRebecca De LorenzoPaola M V RancoitaFederica CugnataAlessandra AgrestiFrancesco BenedettiMarco E BianchiChiara BoniniAnnalisa CapobiancoCaterina ConteAngelo CortiRoberto FurlanPaola ManteganiNorma MaugeriClara ScioratiFabio SaliuLaura SilvestriCristina Tresoldinull nullFabio CiceriPatrizia Rovere-QueriniClelia Di SerioDaniela M CirilloAngelo A ManfrediPublished in: Molecular medicine (Cambridge, Mass.) (2021)
CXCL10 results from a data-driven analysis, that accounts for presence of confounding factors, as the most robust predictive biomarker of patient outcome in COVID-19.